SAN FRANCISCO--(BUSINESS WIRE)-- Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for its third quarter of fiscal 2011.
For the third quarter, Dolby reported total revenue of $219.0 million, compared to $230.3 million for the third quarter of fiscal 2010.
Third quarter GAAP net income was $61.7 million, or $0.55 per diluted share, compared to $63.5 million, or $0.55 per diluted share, for the third quarter of fiscal 2010. On a non-GAAP basis, third quarter net income was $72.8 million, or $0.65 per diluted share, compared to $71.1 million, or $0.62 per diluted share, for the third quarter of fiscal 2010. Dolby's non-GAAP measures exclude expenses related to stock-based compensation, the amortization of intangibles from business combinations, restructuring charges, and the related tax impact of these items.
"Fiscal third quarter licensing growth was led by broadcast and mobile, where we experienced the continued adoption of our formats globally," said Kevin Yeaman, President and Chief Executive Officer, Dolby Laboratories. "In China, Dolby Digital Plus was included as an option in its final digital TV standard, and in Poland the leading free-to-air channel began broadcasting in Dolby Digital Plus."
Financial Targets
For fiscal 2011, Dolby is now targeting revenue of $930 million to $955 million.
GAAP
For fiscal 2011, Dolby continues to target total gross margin of approximately 88 percent. Dolby is now targeting fiscal 2011 operating expenses of $410 million to $417 million and other income of approximately $9 million to $10 million. Dolby continues to target a tax rate of approximately 33 percent for the fourth quarter of fiscal 2011. While stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby is now targeting stock-based compensation expense for fiscal 2011 of approximately $44 million to $45 million. In addition, Dolby is now targeting charges related to the amortization of acquired intangibles for fiscal 2011 of approximately $15 million and continues to target restructuring charges of approximately $1 million to $2 million.
Non-GAAP
For fiscal 2011, Dolby continues to target total gross margin of approximately 89 percent. Dolby is now targeting fiscal 2011 operating expenses of $360 million to $365 million and other income of approximately $9 million to $10 million. Dolby continues to target a tax rate of approximately 33 percent for the fourth quarter of fiscal 2011. Dolby's non-GAAP targets exclude expenses related to stock-based compensation, the amortization of intangibles from business combinations, restructuring charges, and the related tax impact of these items. The non-GAAP measures also exclude the one-time tax benefit resulting from the release of the deferred tax liability for the first quarter of fiscal 2011.
Diluted Earnings per Share
Dolby continues to target diluted shares outstanding of approximately 113 million. These targets lead to an updated fiscal 2011 diluted earnings per share target range of $2.61 to $2.70 on a GAAP basis and $2.87 to $2.96 on a non-GAAP basis.
The Company's Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories' Q3 2011 fiscal year financial results at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, August 4, 2011.
Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 1-888-539-3679. International callers can access the conference call at 1-719-457-2662.
A replay of the call will be available from 5:00 p.m. PT on Thursday, August 4, 2011, until 9:00 p.m. PT on August 11, 2011, by dialing 1-877-870-5176 (international callers can access the replay by dialing 1-858-384-5517) and entering the confirmation code 7456510. An archived version of the teleconference will also be available on Dolby Laboratories' website, www.dolby.com.
Non-GAAP Financial Information
To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides non-GAAP financial measures of gross margin, operating expense, tax rate, and diluted earnings per share. These measures are adjusted to exclude the charges and expenses discussed above. Dolby presents such non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Dolby's management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes the impact of stock-based compensation expense, amortization of intangible assets acquired through business combinations, restructuring charges, and the related tax impact of all of these items on the provision for income taxes, and the non-GAAP measures that exclude such information in order to assess the performance of Dolby's business for planning and forecasting in subsequent periods. Dolby's management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses such a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its SEC filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on our investor relations website at http://investor.dolby.com/medialist.cfm.
Forward-Looking Statements
Certain statements in this press release, including statements relating to Dolby's expectations regarding revenue, gross margin, operating expense, tax rate, stock-based compensation, amortization of intangibles, restructuring charges, and diluted earnings per share for fiscal 2011, and its statements regarding continued adoption of its formats, and the benefits that may be derived from them are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks that Dolby® technologies may not be included in future PC operating systems; risks associated with trends in the markets in which Dolby operates, including the personal computer, DVD and Blu-ray Disc™, broadcast, consumer electronics, gaming, mobile, and automobile markets; pricing pressures; risks that shifts from disc-based media to online media content could result in fewer devices with Dolby technologies; risks associated with the effects of macroeconomic conditions; the timing of Dolby's receipt of royalty reports and/or payments from its licensees; Dolby's accuracy of calculation of royalties due to its licensors; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; the development and growth of the market for digital cinema and digital 3D and Dolby's ability to successfully penetrate this market; Dolby's ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, by acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's Securities and Exchange Commission filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE:DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound, Dolby creates innovations that enrich entertainment at the movies, at home, or on the go. For more information about Dolby Laboratories or Dolby technologies, please visit www.dolby.com.
Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. Blu-ray Disc is a trademark of Blu-ray Disc Association. S11/24673 DLB-F
| |
|
|
|
|
|
|
|
|
|
| DOLBY LABORATORIES, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| |
|
|
|
|
|
|
|
|
|
| |
|
Fiscal Quarter Ended |
|
|
Fiscal Year-to-Date Ended |
| |
|
June 25,
2010 |
|
July 1,
2011
|
|
|
June 25,
2010 |
|
July 1,
2011
|
| |
|
(unaudited) |
| |
|
(in thousands, except per share amounts) |
| Revenue: |
|
|
|
|
|
|
|
|
|
| Licensing |
|
$ |
170,326 |
|
|
$ |
181,790 |
|
|
|
$ |
532,045 |
|
|
$ |
584,593 |
|
| Product sales |
|
|
52,651 |
|
|
|
28,395 |
|
|
|
|
140,147 |
|
|
|
100,769 |
|
| Services |
|
|
7,292 |
|
|
|
8,814 |
|
|
|
|
22,714 |
|
|
|
26,375 |
|
| Total revenue |
|
|
230,269 |
|
|
|
218,999 |
|
|
|
|
694,906 |
|
|
|
711,737 |
|
| |
|
|
|
|
|
|
|
|
|
| Cost of revenue: |
|
|
|
|
|
|
|
|
|
| Cost of licensing |
|
|
3,719 |
|
|
|
4,095 |
|
|
|
|
13,282 |
|
|
|
13,827 |
|
| Cost of products (1) |
|
|
23,336 |
|
|
|
20,320 |
|
|
|
|
72,042 |
|
|
|
62,549 |
|
| Cost of services (1) |
|
|
3,407 |
|
|
|
3,518 |
|
|
|
|
10,554 |
|
|
|
9,153 |
|
| Impairment of products provided under operating leases |
|
|
9,594 |
|
|
|
- |
|
|
|
|
9,594 |
|
|
|
- |
|
| Total cost of revenue |
|
|
40,056 |
|
|
|
27,933 |
|
|
|
|
105,472 |
|
|
|
85,529 |
|
| Gross margin |
|
|
190,213 |
|
|
|
191,066 |
|
|
|
|
589,434 |
|
|
|
626,208 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
| Research and development (1) |
|
|
27,513 |
|
|
|
34,086 |
|
|
|
|
75,561 |
|
|
|
90,812 |
|
| Sales and marketing (1) |
|
|
36,527 |
|
|
|
36,726 |
|
|
|
|
93,635 |
|
|
|
112,488 |
|
| General and administrative (1) |
|
|
29,165 |
|
|
|
32,397 |
|
|
|
|
86,677 |
|
|
|
104,594 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restructuring charges, net |
|
|
1,068 |
|
|
|
(48 |
) |
|
|
|
1,371 |
|
|
|
737 |
|
| Total operating expenses |
|
|
94,273 |
|
|
|
103,161 |
|
|
|
|
257,244 |
|
|
|
308,631 |
|
| Operating income |
|
|
95,940 |
|
|
|
87,905 |
|
|
|
|
332,190 |
|
|
|
317,577 |
|
| Other income, net |
|
|
2,142 |
|
|
|
2,546 |
|
|
|
|
6,200 |
|
|
|
6,434 |
|
| Income before provision for income taxes |
|
|
98,082 |
|
|
|
90,451 |
|
|
|
|
338,390 |
|
|
|
324,011 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Provision for income taxes |
|
|
(34,394 |
) |
|
|
(28,404 |
) |
|
|
|
(118,890 |
) |
|
|
(92,717 |
) |
| Net income including controlling interest |
|
|
63,688 |
|
|
|
62,047 |
|
|
|
|
219,500 |
|
|
|
231,294 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Less: net income attributable to controlling interest |
|
|
(236 |
) |
|
|
(299 |
) |
|
|
|
(1,064 |
) |
|
|
(1,098 |
) |
| Net income attributable to Dolby Laboratories, Inc. |
|
$ |
63,452 |
|
|
$ |
61,748 |
|
|
|
$ |
218,436 |
|
|
$ |
230,196 |
|
| |
|
|
|
|
|
|
|
|
|
| Earnings per share attributable to Dolby Laboratories, Inc. (basic) |
|
$ |
0.56 |
|
|
$ |
0.55 |
|
|
|
$ |
1.92 |
|
|
$ |
2.06 |
|
| Earnings per share attributable to Dolby Laboratories, Inc. (diluted) |
|
$ |
0.55 |
|
|
$ |
0.55 |
|
|
|
$ |
1.89 |
|
|
$ |
2.03 |
|
| |
|
|
|
|
|
|
|
|
|
| Weighted-average shares outstanding (basic) |
|
|
113,254 |
|
|
|
111,494 |
|
|
|
|
113,775 |
|
|
|
111,893 |
|
| Weighted-average shares outstanding (diluted) |
|
|
115,282 |
|
|
|
112,349 |
|
|
|
|
115,780 |
|
|
|
113,165 |
|
| |
|
|
|
|
|
|
|
|
|
| (1) Stock-based compensation included above was classified as follows: |
|
|
|
|
|
|
|
|
|
| Cost of products |
|
$ |
126 |
|
|
$ |
169 |
|
|
|
$ |
305 |
|
|
$ |
483 |
|
| Cost of services |
|
|
36 |
|
|
|
47 |
|
|
|
|
99 |
|
|
|
129 |
|
| Research and development |
|
|
1,869 |
|
|
|
2,632 |
|
|
|
|
4,613 |
|
|
|
7,566 |
|
| Sales and marketing |
|
|
2,573 |
|
|
|
3,429 |
|
|
|
|
6,522 |
|
|
|
9,792 |
|
| General and administrative |
|
|
3,540 |
|
|
|
4,639 |
|
|
|
|
9,476 |
|
|
|
14,946 |
|
| |
|
|
|
|
|
DOLBY LABORATORIES, INC.
|
| CONDENSED CONSOLIDATED BALANCE SHEETS |
| |
|
|
|
|
| |
|
September 24,
2010 |
|
July 1,
2011
|
| |
|
(unaudited) |
| |
|
(in thousands) |
| ASSETS |
|
|
|
|
| Current assets: |
|
|
|
|
| Cash and cash equivalents |
|
$ |
545,861 |
|
$ |
594,604 |
| Short-term investments |
|
|
302,269 |
|
|
309,067 |
| Accounts receivable, net |
|
|
54,257 |
|
|
39,370 |
| Inventories |
|
|
28,338 |
|
|
23,416 |
| Deferred taxes |
|
|
102,758 |
|
|
91,401 |
| Prepaid expenses and other current assets |
|
|
26,930 |
|
|
36,058 |
| Total current assets |
|
|
1,060,413 |
|
|
1,093,916 |
| Long-term investments |
|
|
190,837 |
|
|
280,380 |
| Property, plant and equipment, net |
|
|
94,097 |
|
|
108,334 |
| Intangible assets, net |
|
|
67,019 |
|
|
55,463 |
| Goodwill |
|
|
264,580 |
|
|
268,009 |
| Deferred taxes |
|
|
19,948 |
|
|
18,811 |
| Other non-current assets |
|
|
14,878 |
|
|
6,314 |
| Total assets |
|
$ |
1,711,772 |
|
$ |
1,831,227 |
| |
|
|
|
|
| LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
| Current liabilities: |
|
|
|
|
| Accounts payable and accrued liabilities |
|
$ |
148,214 |
|
$ |
119,965 |
| Income taxes payable |
|
|
7,895 |
|
|
3,675 |
| Deferred revenue |
|
|
9,647 |
|
|
12,976 |
| Total current liabilities |
|
|
165,756 |
|
|
136,616 |
| Long-term deferred revenue |
|
|
12,775 |
|
|
14,850 |
| Deferred taxes |
|
|
11,547 |
|
|
621 |
| Other non-current liabilities |
|
|
27,015 |
|
|
23,274 |
| Total liabilities |
|
|
217,093 |
|
|
175,361 |
| Stockholders' equity: |
|
|
|
|
| Class A common stock |
|
|
53 |
|
|
53 |
| Class B common stock |
|
|
59 |
|
|
58 |
| Additional paid-in capital |
|
|
329,902 |
|
|
255,575 |
| Retained earnings |
|
|
1,135,922 |
|
|
1,366,118 |
| Accumulated other comprehensive income |
|
|
7,801 |
|
|
11,895 |
| Total stockholders' equity - Dolby Laboratories, Inc. |
|
|
1,473,737 |
|
|
1,633,699 |
| Controlling interest |
|
|
20,942 |
|
|
22,167 |
| Total stockholders' equity |
|
|
1,494,679 |
|
|
1,655,866 |
| Total liabilities and stockholders' equity |
|
$ |
1,711,772 |
|
$ |
1,831,227 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| DOLBY LABORATORIES, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
Fiscal Quarter Ended |
|
|
|
Fiscal Year-to-Date Ended |
|
| |
|
|
|
June 25,
2010
|
|
July 1,
2011
|
|
|
|
June 25,
2010
|
|
July 1,
2011
|
| |
|
|
|
(unaudited) |
|
| |
|
|
|
(in thousands) |
|
| Operating activities: |
|
|
|
|
|
|
|
|
|
|
|
| Net income including controlling interest |
|
$ |
63,688 |
|
|
$ |
62,047 |
|
|
|
$ |
219,500 |
|
|
$ |
231,294 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization |
|
|
8,151 |
|
|
|
12,930 |
|
|
|
|
25,545 |
|
|
|
33,975 |
|
| Stock-based compensation |
|
|
8,144 |
|
|
|
10,916 |
|
|
|
|
21,015 |
|
|
|
32,916 |
|
| Amortization of premium on investments |
|
|
2,406 |
|
|
|
4,570 |
|
|
|
|
6,384 |
|
|
|
12,375 |
|
| Excess tax benefit from exercise of stock options |
|
|
(6,606 |
) |
|
|
(1,338 |
) |
|
|
|
(16,890 |
) |
|
|
(12,643 |
) |
| Provision for doubtful accounts |
|
|
27 |
|
|
|
(28 |
) |
|
|
|
(181 |
) |
|
|
828 |
|
| Losses on Put Rights |
|
|
3,755 |
|
|
|
- |
|
|
|
|
6,506 |
|
|
|
- |
|
| Gains on auction rate certificates |
|
|
(4,687 |
) |
|
|
-
|
|
|
|
|
(7,601 |
) |
|
|
- |
|
| Deferred income taxes |
|
|
(11,352 |
) |
|
|
2,045 |
|
|
|
|
(21,782 |
) |
|
|
1,573 |
|
|
Impairment of products provided under operating leases
|
|
|
9,594 |
|
|
-
|
|
|
|
|
9,594 |
|
|
-
|
|
| Payment on litigation settlement |
|
|
(3,000 |
) |
|
|
(3,000 |
) |
|
|
|
(3,000 |
) |
|
|
(3,000 |
) |
| Other non-cash items affecting net income |
|
|
1,241 |
|
|
|
18 |
|
|
|
|
2,007 |
|
|
|
175 |
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
| Accounts receivable |
|
|
(3,148 |
) |
|
|
34,283 |
|
|
|
|
(24,595 |
) |
|
|
14,065 |
|
| Inventories |
|
|
(6,504 |
) |
|
|
7,965 |
|
|
|
|
(4,087 |
) |
|
|
4,927 |
|
| Prepaid expenses and other assets |
|
|
2,467 |
|
|
|
(3,003 |
) |
|
|
|
15,730 |
|
|
|
(6,718 |
) |
| Accounts payable and accrued liabilities |
|
|
17,461 |
|
|
|
(13,738 |
) |
|
|
|
23,759 |
|
|
|
(27,789 |
) |
| Income taxes, net |
|
|
(1,609 |
) |
|
|
5,766 |
|
|
|
|
31,903 |
|
|
|
6,386 |
|
| Deferred revenues |
|
|
(4,744 |
) |
|
|
3,412 |
|
|
|
|
(24,282 |
) |
|
|
5,400 |
|
| Other non-current liabilities |
|
|
(315 |
) |
|
|
(278 |
) |
|
|
|
(74 |
) |
|
|
395 |
|
| Net cash provided by operating activities |
|
|
74,969 |
|
|
|
122,567 |
|
|
|
|
259,451 |
|
|
|
294,159 |
|
| Investing activities: |
|
|
|
|
|
|
|
|
|
|
|
| Purchases of available-for-sale securities |
|
|
(179,439 |
) |
|
|
(86,788 |
) |
|
|
|
(556,172 |
) |
|
|
(454,795 |
) |
|
Proceeds from sales and maturities of available-for-sale securities
|
|
|
287,159 |
|
|
|
107,243 |
|
|
|
|
519,857 |
|
|
|
345,619 |
|
| Purchases of property, plant and equipment |
|
|
(6,989 |
) |
|
|
(10,782 |
) |
|
|
|
(24,882 |
) |
|
|
(30,334 |
) |
| Acquisitions, net of cash acquired |
|
|
- |
|
|
|
- |
|
|
|
|
- |
|
|
|
(3,350 |
) |
| Other investments |
|
|
(700 |
) |
|
|
- |
|
|
|
|
(825 |
) |
|
|
- |
|
|
Proceeds from sales of property, plant and equipment and assets held for sale
|
|
|
- |
|
|
|
280 |
|
|
|
|
- |
|
|
|
3,077 |
|
| Net cash used in investing activities |
|
|
100,031 |
|
|
|
9,953 |
|
|
|
|
(62,022 |
) |
|
|
(139,783 |
) |
| Financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Repayment of long-term debt
|
|
|
(402 |
) |
|
|
- |
|
|
|
|
(1,192 |
) |
|
|
- |
|
|
Proceeds from issuance of Class A common stock (Employee Stock Purchase Plan)
|
|
|
2,139 |
|
|
|
2,893 |
|
|
|
|
4,060 |
|
|
|
5,429 |
|
| Net proceeds from exercise of stock options |
|
|
13,790 |
|
|
|
4,812 |
|
|
|
|
32,948 |
|
|
|
17,491 |
|
| Repurchase of common stock |
|
|
(94,524 |
) |
|
|
(67,376 |
) |
|
|
|
(177,648 |
) |
|
|
(142,500 |
) |
|
Excess tax benefit from exercise of stock options
|
|
|
6,606 |
|
|
|
1,338 |
|
|
|
|
16,890 |
|
|
|
12,643 |
|
| Net cash used in financing activities |
|
|
(72,391 |
) |
|
|
(58,333 |
) |
|
|
|
(124,942 |
) |
|
|
(106,937 |
) |
| Effect of foreign exchange rate changes on cash |
|
|
(860 |
) |
|
|
149 |
|
|
|
|
(5,067 |
) |
|
|
1,304 |
|
| Net decrease in cash and cash equivalents |
|
|
101,749 |
|
|
|
74,336 |
|
|
|
|
67,420 |
|
|
|
48,743 |
|
| Cash and cash equivalents at beginning of period |
|
|
417,349 |
|
|
|
520,268 |
|
|
|
|
451,678 |
|
|
|
545,861 |
|
| Cash and cash equivalents at end of period |
|
$ |
519,098 |
|
|
$ |
594,604 |
|
|
|
$ |
519,098 |
|
|
$ |
594,604 |
|
| |
|
|
|
|
|
GAAP to Non-GAAP Reconciliations
|
| (In millions, except per share data) |
| |
|
|
|
|
| The following tables show the Company's third quarter of fiscal years 2010 and 2011 GAAP financial measures reconciled to non-GAAP financial measures included in this release: |
| |
| Net income: |
|
Fiscal Quarter Ended |
| |
|
June 25,
2010
|
|
July 1,
2011
|
| GAAP net income |
|
$ |
63.5 |
|
|
$ |
61.7 |
|
| Stock-based compensation |
|
|
8.1 |
|
|
|
10.9 |
|
| Amortization of acquired intangibles |
|
|
2.5 |
|
|
|
5.2 |
|
| Restructuring charges, net |
|
|
1.1 |
|
|
|
- |
|
| Income tax adjustments |
|
|
(4.1 |
) |
|
|
(5.0 |
) |
| Non-GAAP net income |
|
$ |
71.1 |
|
|
$ |
72.8 |
|
| |
|
|
|
|
| Diluted earnings per share: |
|
Fiscal Quarter Ended |
| |
|
June 25,
2010 |
|
July 1,
2011
|
| GAAP diluted earnings per share |
|
$ |
0.55 |
|
|
$ |
0.55 |
|
| Stock-based compensation |
|
|
0.07 |
|
|
|
0.10 |
|
| Amortization of acquired intangibles |
|
|
0.02 |
|
|
|
0.05 |
|
| Restructuring charges, net |
|
|
0.01 |
|
|
|
- |
|
| Income tax adjustments |
|
|
(0.03 |
) |
|
|
(0.05 |
) |
| Non-GAAP diluted earnings per share |
|
$ |
0.62 |
|
|
$ |
0.65 |
|
| |
|
|
|
|
| Shares used in computing diluted earnings per share |
|
|
115 |
|
|
|
112 |
|
| |
|
|
|
|
| The following tables show the Company's fiscal year 2011 GAAP financial targets reconciled to non-GAAP financial targets included in this release (numbers are approximate): |
| |
|
|
|
|
| Gross margin: |
|
|
|
|
| |
|
|
|
Fiscal Year 2011 |
| GAAP gross margin |
|
|
|
|
88 |
% |
| Stock-based compensation |
|
|
|
|
0 |
% |
| Amortization of acquired intangibles |
|
|
|
|
1 |
% |
| Non-GAAP gross margin |
|
|
|
|
89 |
% |
| |
|
|
|
|
| Products gross margin: |
|
Fiscal Year 2011 |
| |
|
Low |
|
High |
| GAAP products gross margin |
|
|
37 |
% |
|
|
38 |
% |
| Stock-based compensation |
|
|
1 |
% |
|
|
1 |
% |
| Amortization of acquired intangibles |
|
|
1 |
% |
|
|
1 |
% |
| Non-GAAP products gross margin |
|
|
39 |
% |
|
|
40 |
% |
| |
|
|
|
|
| Operating expenses: |
|
Fiscal Year 2011 |
| |
|
Low |
|
High |
| GAAP operating expenses |
|
$ |
410 |
|
|
$ |
417 |
|
| Stock-based compensation |
|
|
(43 |
) |
|
|
(44 |
) |
| Amortization of acquired intangibles |
|
|
(6 |
) |
|
|
(6 |
) |
| Restructuring charges, net |
|
|
(1 |
) |
|
|
(2 |
) |
| Non-GAAP operating expenses |
|
$ |
360 |
|
|
$ |
365 |
|
| |
|
|
|
|
| Diluted earnings per share: |
|
Fiscal Year 2011 |
| |
|
Low |
|
High |
| GAAP diluted earnings per share |
|
$ |
2.61 |
|
|
$ |
2.70 |
|
| Stock-based compensation |
|
|
0.39 |
|
|
|
0.40 |
|
| Amortization of acquired intangibles |
|
|
0.14 |
|
|
|
0.14 |
|
| Restructuring charges, net |
|
|
0.01 |
|
|
|
0.01 |
|
| Income tax adjustments |
|
|
(0.28 |
) |
|
|
(0.29 |
) |
| Non-GAAP diluted earnings per share |
|
$ |
2.87 |
|
|
$ |
2.96 |
|
| |
|
|
|
|
| Shares used in computing diluted earnings per share |
|
|
113 |
|
|
|
113 |
|
Dolby Laboratories
Investor Contact:
Alex Hughes, 415-645-4572
investor@dolby.com
Media Contact:
Sean Durkin, 415-645-5176
news@dolby.com
Source: Dolby Laboratories, Inc.